{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:21:40Z","timestamp":1785860500166,"version":"3.56.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Skin grafting remains a fundamental reconstructive technique in reconstructive and dermatologic surgery for restoring skin integrity following burns, trauma, chronic ulcers, and excision of malignancies. However, a graft survival rate is determined by multiple factors and by a delicate balance between inflammatory and reparative immune system processes. Controlled inflammation promotes wound healing while excessive or prolonged immune activation has the potential to result in cytotoxicity and complement activation which will eventually lead to graft rejection. Early rejection is driven by antibody-meditated complement cascade and innate effector cells like macrophages and natural killer (NK) cells while long-term graft rejection often results from T cell-mediated cytotoxicity and alloantibody production. Molecular mediators such as reacting oxygen species, pro-inflammatory cytokines, and matrix metalloproteinases (MMP) further amplify tissue injury and prevent healing. Current immunosuppressive therapies like calcineurin inhibitors and different corticosteroids reduce rejection to a certain level and are limited by systemic toxicity and impaired wound healing. Emerging strategies including bioengineered scaffolds, localized cytokine inhibitors, and stem cell-derived factors offer targeted immunomodulation to enhance graft tolerance and long-term survival. Despite promising preclinical data, translation into humans and application of the new emerging therapies remain constrained by species differences, ethical considerations, and variability in patient immune profiles. Advancing humanized models, biomaterial-based therapies, and precision immunotherapy will be pivotal in optimizing graft outcomes. This review aims to highlight how strategic modulation of inflammatory pathways can predict better graft outcomes and pave the way for next-generation regenerative therapies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1780278","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:28:48Z","timestamp":1773120528000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond rejection: engineering immune responses to redefine skin graft survival"],"prefix":"10.3389","volume":"17","author":[{"given":"Daniela","family":"Grinis","sequence":"first","affiliation":[{"name":"Department of Basic Science, Touro College of Osteopathic Medicine","place":["Great Falls, MT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Bouzaglou","sequence":"additional","affiliation":[{"name":"Department of Basic Science, Touro College of Osteopathic Medicine","place":["Harlem, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish R.","family":"Maskey","sequence":"additional","affiliation":[{"name":"Department of Basic Science, Touro College of Osteopathic Medicine","place":["Great Falls, MT, United States"]},{"name":"Department of Pathology, Microbiology & Immunology, New York Medical College","place":["Valhalla, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.4103\/1673-5374.322445","article-title":"Functional and immunological peculiarities of peripheral nerve allografts","volume":"17","author":"Roballo Kelly","year":"2022","journal-title":"Neural Regener Res"},{"key":"B2","article-title":"Split-thickness skin grafts","volume-title":"StatPearls","author":"Braza","year":"2025"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/jbcr\/irae036.102","article-title":"the long-term economic burden of burn injury","volume":"45","author":"Dougherty","year":"2024","journal-title":"J Burn Care Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12893-025-03021-5","article-title":"Split-thickness skin graft outcomes and associated risk factors in patients with skin defects at Al-Gumhouri hospital, Sana\u2019a, Yemen: a prospective observational study","volume":"25","author":"Abdulmughni","year":"2025","journal-title":"BMC Surg"},{"key":"B5","unstructured":"Burns"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(01)00116-9","article-title":"Dendritic cells in transplantation\u2014Friend or foe","volume":"14","author":"Lechler","year":"2001","journal-title":"Immunity"},{"key":"B7","article-title":"T cell-mediated cytotoxicity","volume-title":"Immunobiology: the immune system in health and disease 5th edition","author":"Charles A Janeway","year":"2001"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.974087","article-title":"The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy","volume":"13","author":"Botticelli","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000000041","article-title":"Innate immune cells in transplantation","volume":"19","author":"Spahn","year":"2014","journal-title":"Curr Opin Organ Transplantation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.gastro.2010.10.059","article-title":"Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs","volume":"140","author":"S\u00e1nchez\u2013Fueyo","year":"2011","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2217\/imt.11.2","article-title":"Immune recognition and rejection of allogeneic skin grafts","volume":"3","author":"Benichou","year":"2011","journal-title":"Immunotherapy"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000000263","article-title":"Direct and indirect allograft recognition: pathways dictating graft rejection mechanisms","volume":"21","author":"Lin","year":"2016","journal-title":"Curr Opin Organ Transplantation"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-3274(02)00055-2","article-title":"Pathways of allorecognition: implications for transplantation tolerance","volume":"10","author":"Game","year":"2002","journal-title":"Transplant Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"13196","DOI":"10.3389\/ti.2024.13196","article-title":"Activation and regulation of indirect alloresponses in transplanted patients with donor specific antibodies and chronic rejection","volume":"37","author":"Basu","year":"2024","journal-title":"Transpl Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/01.PRS.0000041445.76730.23","article-title":"Effects of burn wound excision on bacterial colonization and invasion: plastic and reconstructive surgery","volume":"111","author":"Barret","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion\u2014from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nri3225","article-title":"The role of complement in the early immune response to transplantation","volume":"12","author":"Sacks","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(03)00100-6","article-title":"Role of the complement system in rejection","volume":"15","author":"Sacks","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s13770-023-00525-0","article-title":"Immunomodulation for tissue repair and regeneration","volume":"20","author":"Moon","year":"2023","journal-title":"Tissue Eng Regener Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1189\/jlb.0409236","article-title":"The phenotype of murine wound macrophages","volume":"87","author":"Daley","year":"2009","journal-title":"J Leukocyte Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2005.08.023","article-title":"New technologies for burn wound closure and healing\u2014Review of the literature","volume":"31","author":"Atiyeh","year":"2005","journal-title":"Burns"},{"key":"B24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/bmj.38376.439653.D3","article-title":"Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials","volume":"330","author":"Ashcroft","year":"2005","journal-title":"BMJ"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2012.11.018","article-title":"Corticosteroids and wound healing: clinical considerations in the perioperative period","volume":"206","author":"Wang","year":"2013","journal-title":"Am J Surgery"},{"key":"B26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00005-013-0233-2","article-title":"Fundamental immunology of skin transplantation and key strategies for tolerance induction","volume":"61","author":"Zhou","year":"2013","journal-title":"Arch Immunol Ther Exp"},{"key":"B27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13036-017-0089-9","article-title":"Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin","volume":"11","author":"Dixit","year":"2017","journal-title":"J Biol Eng"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s40472-024-00453-5","article-title":"Regenerative medicine approaches for skin wound healing: from allografts to engineered skin substitutes","volume":"11","author":"Mahajan","year":"2024","journal-title":"Curr Transpl Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"09636897221148771","DOI":"10.1177\/09636897221148771","article-title":"Xenotransplantation: current challenges and emerging solutions","volume":"32","author":"Arabi","year":"2023","journal-title":"Cell Transplant"},{"key":"B30","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/ijms18040789","article-title":"Advances in skin regeneration using tissue engineering","volume":"18","author":"Vig","year":"2017","journal-title":"IJMS"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1038\/s41598-018-38366-w","article-title":"In situ bioprinting of autologous skin cells accelerates wound healing of extensive excisional full-thickness wounds","volume":"9","author":"Albanna","year":"2019","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2005.14.1.26721","article-title":"An investigation of the long-term bioactivity of endogenous growth factor in OASIS Wound Matrix","volume":"14","author":"Hodde","year":"2005","journal-title":"J Wound Care"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.168534","article-title":"Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis","volume":"58","author":"Gonzalez-Rey","year":"2009","journal-title":"Gut"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2008.01.051","article-title":"Translational research: From benchside to bedside","volume":"39","author":"Keramaris","year":"2008","journal-title":"Injury"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3727\/096368910X508762","article-title":"Mesenchymal stem cells: mechanisms of immunomodulation and homing","volume":"19","author":"Yagi","year":"2010","journal-title":"Cell Transplant"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/bip.22486","article-title":"Collagen-based biomaterials for wound healing","volume":"101","author":"Chattopadhyay","year":"2014","journal-title":"Biopolymers"},{"key":"B37","doi-asserted-by":"publisher","first-page":"108536","DOI":"10.1016\/j.intimp.2022.108536","article-title":"An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)","volume":"105","author":"Elahi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(25)00129-3","article-title":"Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial","volume":"10","author":"Danese","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1780278\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:28:51Z","timestamp":1773120531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1780278\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2026.1780278"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1780278","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"article-number":"1780278"}}